---
title: Urumin
slug: urumin
qid: 
snapshot: enwiki-001311947522
content_hash: 
license: CC BY-SA 4.0
source: https://en.wikipedia.org/w/index.php?oldid=1311947522
tags: [106462793, 106462794, 23031262, 23603337, 26220375, 26974466, 43371250, 48238993, 50769796, 54374437, 68150358, 73570092]
---

# Urumin

> [!note] Provenance
> Snapshot `enwiki-001311947522` · content root `…`
> Derived from <https://en.wikipedia.org/w/index.php?oldid=1311947522> · Licensed CC BY-SA 4.0

Urumin is a naturally occurring 27-amino acid virucidal host defense peptide against the human influenza A virus. It was discovered and isolated from the skin of Hydrophylax bahuvistara, a species of frog found in South India, by a team of Emory University researchers. The team that discovered urumin tested the peptide against 8 different H1N1 and 4 different H3N2 viruses, as well as various other influenza viruses. The peptide specifically targets the evolutionarily conserved H1 hemagglutinin stalk region of H1-containing influenza A viruses. Additionally, urumin was active against drug-resistant influenza A viruses, that were resistant against oseltamivir, zanamivir, and peramivir. While its mechanism of action is not fully understood, urumin seems to inhibit viral growth by physically destroying influenza A virions, and is able to protect naive mice from doses of influenza A infection as high as twice the . Because of its specific targeting of the hemagglutinin stalk region of the influenza A virus, the mechanism of action of urumin is similar to that of antibodies induced in the body by universal influenza vaccines. Urumin was also tested for toxicity against erythrocytes and showed a TD 50 of 2,450 μM and TI of 664.7, indicating a favorable toxicity profile against erythrocytes.…

Urumin is a naturally occurring 27-amino acid virucidal host defense peptide against the human influenza A virus. It was discovered and isolated from the skin of Hydrophylax bahuvistara, a species of frog found in South India, by a team of Emory University researchers. The team that discovered urumin tested the peptide against 8 different H1N1 and 4 different H3N2 viruses, as well as various other influenza viruses. The peptide specifically targets the evolutionarily conserved H1 hemagglutinin stalk region of H1-containing influenza A viruses. Additionally, urumin was active against drug-resistant influenza A viruses, that were resistant against oseltamivir, zanamivir, and peramivir. While its mechanism of action is not fully understood, urumin seems to inhibit viral growth by physically destroying influenza A virions, and is able to protect naive mice from doses of influenza A infection as high as twice the . Because of its specific targeting of the hemagglutinin stalk region of the influenza A virus, the mechanism of action of urumin is similar to that of antibodies induced in the body by universal influenza vaccines. Urumin was also tested for toxicity against erythrocytes and showed a TD 50 of 2,450 μM and TI of 664.7, indicating a favorable toxicity profile against erythrocytes. As such, urumin may represent the basis for a potential first-line antiviral treatment against influenza A, particularly in the context of influenza outbreaks, although the discoverers of the peptide have stated that urumin is far from becoming an anti-flu drug. Urumin was named after the urumi, a sword used in Kalaripayattu, the martial art of Kerala, where urumin was discovered. ==References==
